Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Global Postmenopausal Osteoporosis Drugs Market 2016-2020

146 views

Published on

Technavio’s market research analyst predicts the global postmenopausal osteoporosis drugs market to grow steadily at a CAGR of more than 4% over the forecast period. With the expected launch of promising pipeline molecules, the market for postmenopausal osteoporosis has a positive outlook in the coming years. The postmenopausal osteoporosis drugs market is characterized by the presence of promising late-stage molecules that are being developed by the major and upcoming players in this market. Some of the late-stage pipeline molecules that are envisaged to be launched during the forecast period are Tarsa Therapeutics’ TBRIA, romosozumab, Merck’ odanacatib (Phase III), and Radius Health’s abaloparatide (Phase III).

Published in: Healthcare
  • Be the first to comment

  • Be the first to like this

Global Postmenopausal Osteoporosis Drugs Market 2016-2020

  1. 1. USA – CANADA – UK – CHINA – INDIA Global Postmenopausal Osteoporosis Drugs Market 2016-2020
  2. 2. USA – CANADA – UK – CHINA – INDIA Scope of The Report • Market landscape of global postmenopausal osteoporosis drugs market • Market size and forecast of global postmenopausal osteoporosis drugs market • Key market highlights of global postmenopausal osteoporosis drugs market • Understanding the challenges faced by the market • Enabling technologies and the roadmap • Key focus areas for the vendors • Major trends that will shape the future of this market • Vendor landscape and trajectory of the market
  3. 3. USA – CANADA – UK – CHINA – INDIA Key Segments • Global postmenopausal osteoporosis drugs market segmentation by therapeutic class • Global postmenopausal osteoporosis drugs market segmentation by line of therapy • Global postmenopausal osteoporosis drugs market segmentation by business • Global postmenopausal osteoporosis drugs market segmentation by vendor • Geographical segmentation of the global postmenopausal osteoporosis drugs market Global Postmenopausal Osteoporosis Drugs Market 2016-2020
  4. 4. USA – CANADA – UK – CHINA – INDIA Growth Rate Technavio’s market research analyst predicts the global postmenopausal osteoporosis drugs market to grow steadily at a CAGR of more than 4% over the forecast period. CAGR:
  5. 5. Key Vendors and Regions Vendors Regions • Eli Lilly • Amgen • Merck • Novartis • Americas • APAC • EMEA View Our Report: Global Postmenopausal Osteoporosis Drugs Market 2016-2020 USA – CANADA – UK – CHINA – INDIA
  6. 6. USA – CANADA – UK – CHINA – INDIA Key Questions Answered in Our Report • What will the market size be in 2020 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors? Have a question of your own about this report? please drop us a mail at enquiry@technavio.com
  7. 7. Related Reports • Osteoporosis Drugs Market in the APAC Region 2015-2019 • Global Hormone Replacement Therapy Market 2015-2019 • Global Postmenopausal Vaginal Atrophy Drugs Market 2016-2020 • Global Osteoporosis Drugs Market 2015-2019 USA – CANADA – UK – CHINA – INDIA Explore our library of 3,000+ insightful, regularly updated reports across niche technology markets and 80+ countries Find Out More >
  8. 8. USA – CANADA – UK – CHINA – INDIA Our Report Covers: Market Scenarios, Vendor landscape & Industry Road Maps. You have the Option to Customize Reports & Access Analysts on every Report Purchase. Write to us We’ll include an hour with our analysts to discuss the report findings with every purchase. For Free Global Postmenopausal Osteoporosis Drugs Market 2016-2020
  9. 9. USA – CANADA – UK – CHINA – INDIA Stay in touch! enquiry@technavio.com Or you can visit us at: www.technavio.com

×